Olanzapine Tablet, Orally Disintegrating
Product Images NDC 64380-174

5 FDA label images from Strides Pharma Science Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 64380-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 01)

Chemical Structure (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 01)
Chemical structure of olanzapine, the active ingredient in Olanzapine orally disintegrating tablets by Strides Pharma Science Limited. The diagram shows the molecular arrangement including rings with nitrogen and sulfur atoms.*
FDA Label Image

Image (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 02)

Image (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 02)
Packaging label for Olanzapine Orally Disintegrating Tablets, USP 5 mg, containing 30 unit dose tablets (3 blister cards with 10 tablets each). The label includes storage instructions, usage directions for removing the tablet from the blister, and safety warnings. Distributed by Strides Pharma Inc.*
FDA Label Image

Image (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 03)

Image (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 03)
Packaging label for Olanzapine Orally Disintegrating Tablets, USP 10 mg. The label indicates a pack containing 30 unit dose tablets (3 blister cards each with 10 tablets) and is distributed by Strides Pharma Inc. Instructions for use include peeling back the foil on the blister and placing the tablet in the mouth. The label includes storage instructions and a warning for phenylketonurics.*
FDA Label Image

Principal Display Panel 15 mg (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 04)

Principal Display Panel 15 mg (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 04)
Packaging label for Olanzapine Orally Disintegrating Tablets, USP, 15 mg strength. The label indicates the product is a 30 unit dose tablet package with 3 blister cards each containing 10 tablets. It is distributed by Strides Pharma Inc. The label includes storage instructions, phenylalanine content warning, NDC 64380-174-02, and simple illustrated instructions for removing tablets from the blister pack and oral administration.*
FDA Label Image

Principal Display Panel 20 mg (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 05)

Principal Display Panel 20 mg (31cbcf44 12cf 4304 Bb82 6c37b8b41a5b 05)
Packaging label for Olanzapine Orally Disintegrating Tablets USP, 20 mg strength. The label indicates a 30-unit dose package containing 3 blister cards, each with 10 tablets. The product is prescription-only, distributed by Strides Pharma Inc., Bridgewater, NJ. The label includes cautionary instructions, storage conditions, and a brief guide for tablet removal from the blister pack.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.